Stent Grafts
Gore wins CE Mark for lower-profile stent-graft components
Arizona medical device maker W.L. Gore & Assoc. announced CE Mark approval in the European Union for new components of its Gore Excluder AAA endoprosthesis in treatment of abdominal aortic aneurysms.
European regulators cleared Gore’s lower-profile 31 mm diameter ipsilateral leg and 32 mm aortic extender, designed for use with the Excluder AAA stent-graft in sealing off aneurysms and creating new paths for blood flow.
Supreme Court denies W.L. Gore in stent graft patent spat with C.R. Bard
The U.S. Supreme Court dashed the last hopes of W.L. Gore & Assoc. in its long-running patent war with C.R. Bard (NYSE:BCR) over vascular graft technology.
Cordis unveils 1-year results for its Incraft AAA stent graft system
Johnson & Johnson (NYSE:JNJ) subsidiary Cordis this month unveiled 1-year clinical findings from a study of its Incraft AAA stent graft system in treating abdominal aortic aneurysms.
The Incraft AAA system is under investigation through the company’s multi-center, prospective, non-randomized INNOVATION study in AAA patients, according to a press release.
Endotach sues Medtronic over stent graft patents
Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan.
The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor’s widow, according to court documents.
Medtronic’s Endurant III graft looks good at 2 years
Medical device giant Medtronic (NYSE:MDT) touted positive 2-year findings for its popular Endurant AAA stent graft system, vindicating previous findings.
Medtronic presented the new data, compiled from a U.S. investigational device exemption study and an international ENGAGE registry of Endurant AAA patients, at the VEITHsymposium in New York this week.
Kips Bay lands FDA approval to begin eSVS mesh study
Kips Bay Medical (NSDQ:KIPS) won conditional FDA investigational device exemption approval for its eSVS mesh, allowing the company to begin a clinical study of the device in use during coronary artery bypass procedures.
Medtronic wins FDA expanded approval for Valiant thoracic stent graft system
Endologix settles patent spat with Cook Medical for $5M
Endologix (NSDQ:ELGX) agreed to pay Cook Medical $5 million to settle a patent infringement lawsuit over stent graft technology.
FDA OKs Bolton Medical’s thoracic stent-graft
Florida-based stent maker Bolton Medical won FDA clearance for its thoracic-specific stent-graft system, the company announced today.
Bolton’s Relay thoracic stent-graft device and delivery system is designed specifically for minimally invasive treatment of thoracic aortic aneurysms and penetrating atherosclerotic ulcers, and it comes in a range of sizes, according to a press release.